发明名称 |
Inhibitors of Protein Kinase a Anchoring |
摘要 |
A PKA I anchoring disrupting molecule or AKAP mimic, wherein said molecule or mimic is a polypeptide which comprises the following amino acid sequence: X<SUB>1 </SUB>X<SUB>2 </SUB>X<SUB>3 </SUB>Y A X<SUB>4 </SUB>X<SUB>5 </SUB>L A X<SUB>6 </SUB>X<SUB>7 </SUB>X<SUB>8 </SUB>I X<SUB>9 </SUB>X<SUB>10 </SUB>X<SUB>11 </SUB>X<SUB>12 </SUB>X<SUB>13 </SUB>(sequence (1)) or a peptidomimetic or analogue thereof is provided. Also provided are antibodies to the molecule, nucleic acid molecules comprising a sequence encoding the molecule and pharmaceutical compositions. A method of altering the PKA type I signalling pathway in a cell by administration of the anchoring disruption molecule or AKAP mimic, in particular to treat immunosuppressive disorders, proliferative diseases or autoimmune diseases is also provided.
|
申请公布号 |
US2008248008(A1) |
申请公布日期 |
2008.10.09 |
申请号 |
US20050575966 |
申请日期 |
2005.09.26 |
申请人 |
CARLSON CATHRINE REIN;TASKEN KJETIL;SCOTT JOHN |
发明人 |
CARLSON CATHRINE REIN;TASKEN KJETIL;SCOTT JOHN |
分类号 |
A61K35/12;A61K31/70;A61K38/00;A61K38/43;A61P37/00;C07K7/08;C07K14/47;C07K16/18;C12N5/06;C12N9/12;C12N15/11;C12P21/04;C12Q1/48 |
主分类号 |
A61K35/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|